Global Image Guided Radiation Therapy (IGRT) Market Size By Type (Soft-Tissue Imaging, Lung MRI), By Application (Hospitals, Smart Cancer Centers), By Region, And Segment Forecasts, 2023 to 2032

lobal Image Guided Radiation Therapy (IGRT) Market Report Description

The Global Image Guided Radiation Therapy (IGRT) Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 4.8 billion by 2031, registering a CAGR of 9.1% during the forecast period (2023–2031).

The market growth is primarily driven by the increasing prevalence of cancer, rising adoption of advanced radiotherapy technologies, and growing demand for precision-based cancer treatments. IGRT integrates advanced imaging techniques such as CT, MRI, and PET scans to accurately target tumors while minimizing damage to healthy tissues. The shift toward personalized oncology care, along with technological advancements in imaging modalities, is fueling the adoption of IGRT globally.

Drivers

Rising Cancer Incidence Worldwide

The global cancer burden is increasing rapidly due to aging populations and lifestyle-related risk factors. This is driving the need for highly precise and effective radiotherapy solutions like IGRT, which reduces recurrence and improves patient survival rates.

Technological Advancements in Imaging & Radiotherapy

Continuous innovations in medical imaging, integration of AI in treatment planning, and the development of hybrid radiotherapy systems are enhancing the accuracy and efficiency of IGRT.

Shift Towards Outpatient & Non-Invasive Treatment

As healthcare providers emphasize cost-effective and less invasive cancer treatments, IGRT is gaining traction for its ability to deliver targeted therapy with minimal side effects.

Restraints

High Installation & Operational Costs

IGRT equipment involves significant capital investment and maintenance expenses, which can limit adoption, especially in low- and middle-income countries.

Shortage of Skilled Professionals

Operating IGRT systems requires specialized expertise, and the lack of trained oncologists and radiotherapists in developing regions is a barrier to market expansion.

Opportunity

Emerging Markets & Healthcare Infrastructure Expansion

Rapid improvements in healthcare infrastructure in Asia-Pacific, Latin America, and the Middle East present lucrative opportunities for IGRT manufacturers.

Integration with AI & Machine Learning

Combining IGRT with AI-powered imaging and treatment planning systems can improve precision, reduce errors, and open new avenues for personalized oncology care.

Growing Adoption of Proton Therapy & Hybrid Systems

The rise of proton therapy and MRI-guided linear accelerators (MR-Linacs) is creating demand for integrated IGRT solutions.

Market by System Type Insights

CT-Guided IGRT held the largest share in 2023 due to its widespread adoption and cost-effectiveness in targeting tumors.

MRI-Guided IGRT is expected to witness the fastest growth during the forecast period, driven by its superior soft-tissue imaging capabilities and improved tumor visualization.

Market by End-Use Insights

Hospitals & Cancer Treatment Centers dominated the market in 2023, accounting for over 65% of the revenue share, owing to the availability of advanced radiotherapy infrastructure.

Specialty Clinics & Research Institutes are expected to grow rapidly as outpatient cancer care and clinical trials expand globally.

Market by Regional Insights

North America led the global IGRT market in 2023 due to high cancer prevalence, well-established healthcare systems, and strong reimbursement policies.

Asia-Pacific is projected to record the highest CAGR, fueled by rising healthcare investments, improving cancer screening programs, and the increasing adoption of advanced oncology solutions in China, India, and Japan.

Europe remains a key market, with countries like Germany, France, and the UK advancing in precision radiotherapy technologies.

Competitive Scenario

Key players operating in the global IGRT market include:

Varian Medical Systems (Siemens Healthineers)

Elekta AB

Accuray Incorporated

ViewRay, Inc.

IBA Dosimetry GmbH

Hitachi Healthcare

C-RAD AB

Brainlab AG

These companies are focusing on strategic partnerships, AI-driven radiotherapy solutions, and geographic expansion to strengthen their global presence.

Key Recent Developments:

2024: Varian (Siemens Healthineers) launched Halcyon 3.0, an advanced IGRT platform with AI-enabled adaptive planning.

2023: Elekta introduced MRI-Linac Harmony Pro, a next-generation MRI-guided radiotherapy system.

2023: Accuray partnered with a leading oncology network to expand access to robotic IGRT systems in Asia-Pacific.

Scope of Work – Global Image Guided Radiation Therapy (IGRT) Market

FAQs

What is the current market size of the Global IGRT Market?

The market was valued at USD 2.4 billion in 2023.

What is the major growth driver of the IGRT Market?

The rising cancer prevalence and technological advancements in precision radiotherapy are the key growth drivers.

Which region is expected to dominate the IGRT Market during the forecast period?

North America is expected to remain the leading market, while Asia-Pacific will witness the highest growth.

Which segment accounted for the largest market share in the IGRT Market?

CT-Guided IGRT systems accounted for the largest share in 2023 due to widespread adoption.

Who are the key market players in the Global IGRT Market?

Major players include Varian (Siemens Healthineers), Elekta AB, Accuray, ViewRay, and Brainlab AG.

Would you like me to also create SEO-friendly meta title & description for this report so it can be published online effectively? Or should I generate another market report description in the same format for a different topic?